Business Context and Reporting Period
This Form 8-K filing by AngioDynamics, Inc. (NASDAQ: ANGO) was submitted on August 16, 2019, reporting an event that occurred on August 13, 2019. The filing addresses corporate governance changes regarding the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific corporate event and does not contain financial performance data.
Material Changes
The material change reported is the departure of a director. Mr. Jeffrey Gold notified the Board of his intention not to stand for reelection at the 2019 Annual Meeting of Stockholders scheduled for October 2019. He will retire at the end of his current term. The filing explicitly states that his resignation is not due to any disagreement related to the Company's operations, policies, or practices. Mr. Gold has served as a director since 1997 and will continue to serve until the election of directors at the upcoming annual meeting.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies beyond the standard disclosure regarding the director's departure.
Key Facts for Investors to Verify
- Mr. Jeffrey Gold will not seek reelection as a director at the October 2019 Annual Meeting.
- Mr. Gold's departure is voluntary and not related to any disagreement with the company.
- Mr. Gold will remain on the Board until the conclusion of the 2019 Annual Meeting.
- The company has not announced a replacement nominee in this specific filing.